Ethan Alt

Brigham and Women's Hospital, United States

Sanofi Genzyme (Employment)

Presentation(s):

• Risk of Hypoglycemia with Sodium Glucose cotransporter-2 Inhibitors vs. Alternative Glucose Lowering Medications in Patients with and Without Baseline Use of Insulin or Sulfonylurea

  Sunday, August 28, 2022
  2:30 PM – 2:45 PM CEST